Invest in Blueprint Medicines Corp (BPMC) Stock with the prospect of future returns

view original post

Stephens raised the price target for the Blueprint Medicines Corp (NASDAQ:BPMC) stock to “an Overweight”. The rating was released on May 14, 2024, according to finviz. We previously noted in another …